Home Immunology Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Immunology JoVE (Open Access) Citable · DOI

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

DOI: 10.3791/53609-v
What you'll learn
  • Perform bioluminescence imaging acquisition under standardized conditions
  • Apply the luminoscore method to quantify tumor burden without complex calculations
  • Monitor tumor progression and treatment response in mouse lymphoma models
Protocol

Bioluminescence imaging is a well-known tool for localizing tumors and metastases, but quantification of these images often requires complex calculations and particular instruments. We describe the easy-to-use luminoscore method, based on precise acquisition conditions, requiring no calculations, and enabling tumor burden and treatment response to be monitored in mouse models.

Difficulty
intermediate
Total time
~15-30 min per imaging session; varies by tumor progression timeline (days to weeks)
Model organism
Mouse (lymphoma xenograft/transgenic models)
Biosafety
BSL-2

Steps

1
Set up bioluminescence imaging system

Configure imaging equipment with precise acquisition parameters to ensure consistent, standardized conditions for reproducible bioluminescence signal detection and quantification.

▶ 00:48
2
Quantify bioluminescence signal using luminoscore

Apply the luminoscore method to acquired images, converting raw bioluminescence data into tumor burden measurements without requiring manual calculations or specialized analysis software.

▶ 02:40
3
Monitor tumor burden and treatment response

Track bioluminescence quantification data over time in mouse lymphoma models to assess tumor progression and evaluate the efficacy of therapeutic interventions.

▶ 03:59
💬 Comments coming soon